Trojan, Jörg http://orcid.org/0000-0001-9414-378X
Article History
First Online: 15 July 2020
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this article.
: Jörg Trojan has received research grants from Roche. He has received speaker and consulting honoraria from Amgen, Astra Zeneca, Bayer Healthcare, Bristol Myers-Squibb, Eisai, Ipsen, Merck Serono, Merck Sharp & Dome, Lilly Imclone, and Roche.